Shulman et al. advanced the idea that diacylglycerols are key players in insulin resistance, through their ability to stimulate a specific isoform of PKC (PKCε), which then phosphorylates T1150 in the catalytic domain of the insulin receptor, inhibiting its tyrosine kinase activity. This evidence concerns the gene INSR and Insulin resistance.